Ascelia Pharma strengthens its Mangoral franchise by filing of a patent application for next generation Mangoral product
Today, Ascelia Pharma AB (publ) (ticker: ACE) (“Ascelia”) announces that it has filed a patent application for a next generation Mangoral product. Upon grant, the new patent would further improve the unique value proposition of Mangoral and extend the intellectual property protection rights until year 2040.Ascelia’s lead imaging drug Mangoral is covered by an Orphan Drug Designation in the US, providing 7 to 7.5 years of market exclusivity after its marketing authorization approval, and in EU/EEA, data exclusivity can prevail from up to 10 years after marketing authorization. With the
Zivid 3D color camera makes first appearance in Japan at Image Sensing ShowOSLO, Norway, June 10, 2019 – Zivid, the 3D machine vision camera company, has made its first distributor appointment in Japan. Micro-Technica will support the company’s Zivid One Plus cameras and software throughout the country and will showcase the product at the forthcoming Image Sensing Show, Yokohama, 12-14 June 2019.
Founded in 1981, Tokyo-based Micro-Technica is a vision inspection specialist operating in
The energy sector, which has traditionally been clear, cyclical, predictable and slow-moving, has suddenly become both a multi-dimensional and multi-problematic market. Drastic policy changes, for example, with regards to the acceptability and future of different energy forms, are increasing globally. Currently, there are no indications that the number of policy changes, or their effectiveness, are likely to decline. It is also believed that the trend towards projects which are considered the most beneficial towards people and nature, will be utilised in the long term, because they save
